Form D · Other
EMPASSION HEALTH HOLDINGS, LLC
New York, NY · CIK 0001921670
Offering snapshot reported Mar 20, 2023 · SEC filing
- Reported sold
- $20M Offering amount: $25M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $67.7K Reported outside-investor minimum
- First sale
- Mar 7, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2023 | Initial | $19,999,986 | No comparison | 12 | SEC filing |
| May 2, 2022 | Initial | $6,925,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-476370
Source: Form D, filed Mar 20, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Baiada | Director |
| Sebastian Caliri | Director |
| Spencer Carrucciu | Director |
| Jared Hawkins | Executive |
| Robin Heffernan | Director, Executive |
| Spencer Jennings | Executive |
| Tom Koutsoumpas | Director |
| David Whelan | Director |
| Burke Wise | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
330 Hudson Street Suite 300
New York, NY, 10013
New York, NY, 10013